| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441491 | European Journal of Cancer | 2016 | 12 Pages |
Abstract
In this meta-analysis based on observational studies, CSS appeared to significantly reduce recurrence among BOT patients. No survival impact was observed. Longer-term randomised controlled trials could verify this relationship but appear infeasible for this rare tumour.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Seung-Hyuk Shim, Soo-Nyung Kim, Phill-Seung Jung, Meari Dong, Jung Eun Kim, Sun Joo Lee,